Companies /Healthcare

Johnson & Johnson

NYSE: JNJ Drug Manufacturers - General
$255.56
▲ $2.28 (+0.90%) today
Markets closed · 1:10am ET

JNJ Coverage Page 74

8:34am ET
Health and Healthcare

Abbott Labs Stung by Foreign Exchange Rate

Abbott Laboratories (NYSE: ABT) reported second-quarter results this morning that beat the consensus estimate for earnings per share (EPS), but missed slightly on revenues. The drug maker reported adjusted diluted EPS of…

Paul Ausick
9:00am ET
Health and Healthcare

Currency Exchange Rates, One-Time Charges Hit J&J

Health care giant Johnson & Johnson (NYSE: JNJ) reported second-quarter earnings this morning, posting adjusted earnings per share (EPS) of $1.30 on revenue of $16.5 billion. The consensus estimate from analysts called…

JNJ
Paul Ausick
7:03am ET
Investing

Ten Brands That Will Disappear In 2013

Each year, 24/7 Wall St. identifies 10 important American brands that we predict will disappear within a year. This year’s list reflects the brutally competitive nature of certain industries and the reason…

Douglas A. McIntyre
6:37am ET
Media

Media Digest (6/6/2012) Reuters, WSJ, NYT, Bloomberg

Nasdaq (NASDAQ: NDAQ) will announce what compensation it will give Facebook (NASDAQ: FB) brokers. (Reuters) The European Union continues to look at ways to help the region’s damaged banks. (Reuters) Spain says it has…

Douglas A. McIntyre
11:35am ET
Health and Healthcare

Dendreon In Trouble

AuthorDendreon Corporation (NASDAQ: DNDN) is in trouble.  That is what the performance is telling investors.  The maker of Provenge as a late-stage prostate cancer treatment has three issues working against it.  The…

JNJ
Jon C. Ogg
6:27am ET
Investing

Avon: Coty Will Be Back

Coty, which had made a $10.7 billion offer to buy Avon Products (NYSE: AVP), withdrew its bid. It said the the Avon board had failed to react to its offer by a…

Douglas A. McIntyre